Literature DB >> 32402627

Re: Novel Coronavirus COVID-19 in late pregnancy: Outcomes of first nine cases in an inner city London hospital.

A Govind1, S Essien1, A Karthikeyan1, A Fakokunde1, D Janga1, W Yoong2, A Nakhosteen3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32402627      PMCID: PMC7204671          DOI: 10.1016/j.ejogrb.2020.05.004

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


× No keyword cloud information.
We would like to share our experience of nine laboratory-proven COVID-19 mothers delivered at a London inner-city hospital between 7th of March and 22nd April 2020. In all cases, positive diagnosis was based on real time reverse transcriptase polymerase chain reaction (RT-PCR) of maternal nasopharygeal swabs. The median age and gestation at delivery were 31 years (range 18–39) and 39 weeks (range 27–39) respectively and two of the nine women were delivered by emergency caesarean section (CS) for COVID-19 pneumonia and deteriorating maternal respiratory function. Of the remaining seven, one mother had a normal vaginal delivery, six underwent elective CS for obstetric indications while an emergency CS was performed in one woman for suboptimal cardiotocography (Table 1 ). Seven of our nine women (78 %) had mild to moderate prodromal symptoms not requiring admission (such as fever, cough, myalgia, sore throat, anosmia): these women were only screened due to a high index of suspicion rather than severity of complaints. The infants were immediately isolated from the mothers at birth and had RT-PCR for SARS-Cov-2 nucleic acid nasal pharyngeal swabs performed. Only one of the nine babies was subsequently confirmed as COVID-19 positive (patient 1) based on nasopharyngeal RT-PCR.
Table 1

showing maternal and fetal outcomes (n = 9).

PatientAge (yrs)ParityCXRGestation (wks)Mode of deliveryIndicationPMHFeverCoughMyalgia and joint painsRunny noseSore throatLethargyDyspnoeaAnosmiaFetal weight (g)Fetal COVID statusFetal outcome
1362 + 0Consolidation38Em CSMaternal pneumonia and respiratory distressGestational diabetesYYNNYYYN4165PositiveViral pneumonia day 6 but recovered well
Apgars 5, 9
2292 + 1Consolidation27Em CSMaternal pneumonia and respiratory distressNoneYYNNNNYY1200NegativeVentilated for 10 days
Apgars 2, 6
3312 + 3Normal35Em CSPathological CTG not in labourNoneYYYNYYYY2700NegativeObservation only due to poor feeding
Apgars 6, 8
4310 + 1Consolidation39El CSBreechAsthmaYNNNYNNY3370NegativeTalipes
Apgars 9, 9
5221 + 0Consolidation38NVDN/ANoneNYYNNYNN4300NegativeWell
Apgars 9, 9
6394 + 1Not done37El CS3 previous CSInsulin dependent diabetes hypertensionNYNNNYNY2500NegativeWell
Apgars 8, 9
7181 + 0Not done39El CSPrevious CS and maternal requestNoneNYYNNNNY3060NegativeWell
Apgars 9, 9
8383 + 1Not done39El CS3 previous CSNoneNYYNYYYY3540NegativeWell
Apgars 9, 9
9340 + 0Not done39El CSMaternal requestNoneNYYNNYNY3560NegativeWell
Apgars 9, 9
showing maternal and fetal outcomes (n = 9). We would like to focus on the first two mothers who were delivered by emergency CS due to inability to maintain oxygen saturation and to highlight the accompanying lymphopenia that were previously described in the cases reported by Sutton [1] and Zheng [2]. Patient 1: A 33 year old woman with diet controlled gestational diabetes mellitus was admitted at 39 weeks gestation with flu-like symptoms and productive cough. A provisional diagnosis of pneumonia was made but she developed chest pain and became tachypnoeic. Chest Xray revealed right basal consolidation and lymphopenia was noted (0.92 × 109/l; normal: 1.2–3.6). Maternal nasopharygeal swabs were positive for SARS-CoV-2 RT-PCR and she underwent an emergency CS for sudden deterioration of respiratory function, requiring 15 L/min of oxygen to maintain saturation of >95 %. A live infant 4.165 kgs was delivered with Apgar scores of 51minute and 95 minutes and was immediately separated from the mother. Following delivery, the patient continued to desaturate (80–85 %) on 100 % of oxygen and was transferred to a tertiary centre for extracorporeal membrane oxygenation (ECMO). The baby, subsequently confirmed as COVID-19 positive, developed pyrexia and exhibited signs of pneumonia on the sixth day but settled with benzylpenicillin and gentamycin. Patient 2: A 29 year old lady was admitted at 27 weeks gestation with myalgia, cough, pyrexia >38.4 °C and dyspnoea. SARS-CoV-2 was diagnosed on basis of nasopharyngeal RT-PCR and chest Xray showed basal consolidation (Fig. 1 ). She was commenced on intravenous clarithromycin and cefuroxime but became tachypnoeic and was unable to maintain oxygen saturation. Lymphopenia (1.05 × 109 /l; normal: 1.2–3.6) was noted and an emergency CS was performed for deteriorating maternal respiratory function. She required mechanical ventilation for four days post-delivery before being “stepped down”. The baby weighing 1.2 kgs with Apgars of 21minute and 65 minutes and required intubation because of prematurity. The baby was negative for nasopharyngeal, amniotic fluid and placental swabs RT-PCR for SARS-CoV-2 and was weaned off ventilation after 10 days.
Fig. 1

Chest Xray of patient 2 showing lower lobe patchy consolidation consistent with (COVID) pneumonia.

Chest Xray of patient 2 showing lower lobe patchy consolidation consistent with (COVID) pneumonia. Table 1 shows that maternal symptoms can be variable and of interest is that cough (8/9) and anosmia (7/9) appear to be the commonest presentations in this small series. We had initially followed advice from Chinese literature which recommended isolation of the infected woman and her baby for 14 days [2]. However, given the limited data and considering the potential detrimental effects on feeding and bonding, the Royal Colleges of Midwifery and Obstetricians and Gynaecologists have now jointly issued a guideline [3] that COVID-19 women and their healthy babies should be kept together in the postpartum period. Similarly, breast milk of affected mothers [4] has tested negative for COVID-19 and current evidence suggest that breast feeding is not contraindicated [3]. The most recent systemic review of six studies involving 48 delivered women indicates low likelihood of vertical transmission [5], although transplacental maternal-fetal transmission have been reported [1,2] including in our first case (where mother and baby were immediately separated and membranes had remained intact until CS). We can postulate that there may be a relationship between vertical transmission with maternal viral load as this was our most respiratory-compromised patient. The same systemic review [5] noted that 96 % of COVID-19 women were delivered by CS; however, we suspect that these were likely to be elective procedures for obstetric indications, like the last four women in our series, where COVID-19 had been detected several weeks prior to delivery in relatively stable patients. We end this letter by reminding clinicians that many pregnant women with COVID-19 present with mild or even no symptoms. In the United Kingdom, we currently do not have the capacity or funds to screen all pregnant women as recommended by Sutton et al. [1] but any recent onset of cough and anosmia warrants a high level of suspicion for screening.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  4 in total

1.  Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China.

Authors:  Lingkong Zeng; Shiwen Xia; Wenhao Yuan; Kai Yan; Feifan Xiao; Jianbo Shao; Wenhao Zhou
Journal:  JAMA Pediatr       Date:  2020-07-01       Impact factor: 16.193

2.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Authors:  Huijun Chen; Juanjuan Guo; Chen Wang; Fan Luo; Xuechen Yu; Wei Zhang; Jiafu Li; Dongchi Zhao; Dan Xu; Qing Gong; Jing Liao; Huixia Yang; Wei Hou; Yuanzhen Zhang
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

3.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

Authors:  Desmond Sutton; Karin Fuchs; Mary D'Alton; Dena Goffman
Journal:  N Engl J Med       Date:  2020-04-13       Impact factor: 91.245

4.  Coronavirus disease 2019 during pregnancy: a systematic review of reported cases.

Authors:  Anna Nunzia Della Gatta; Roberta Rizzo; Gianluigi Pilu; Giuliana Simonazzi
Journal:  Am J Obstet Gynecol       Date:  2020-04-18       Impact factor: 10.693

  4 in total
  24 in total

Review 1.  Maternal and perinatal outcomes of pregnancy associated with COVID-19: Systematic review and meta-analysis.

Authors:  Zekiye Karaçam; Damla Kizilca-Çakaloz; Gizem Güneş-Öztürk; Ayden Çoban
Journal:  Eur J Midwifery       Date:  2022-07-06

Review 2.  Vertical transmission of SARS-CoV-2: A systematic review.

Authors:  Kristine Jeganathan; Anthea Bm Paul
Journal:  Obstet Med       Date:  2022-06

Review 3.  Adverse outcomes in SAR-CoV-2 (COVID-19) and SARS virus related pregnancies with probable vertical transmission.

Authors:  Gulam Bahadur; Roy Homburg; Wai Yoong; Cheentan Singh; Mamta Bhat; Phalguni Kotabagi; Santanu Acharya; Judith Huirne; Pablo Alexis Doreski; Mariusz Łukaszuk; Asif Muneer
Journal:  JBRA Assist Reprod       Date:  2020-07-14

Review 4.  Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review.

Authors:  Rommy H Novoa; Willy Quintana; Pedro Llancarí; Katherine Urbina-Quispe; Enrique Guevara-Ríos; Walter Ventura
Journal:  Travel Med Infect Dis       Date:  2020-11-19       Impact factor: 6.211

Review 5.  Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s.

Authors:  Aniza P Mahyuddin; Abhiram Kanneganti; Jeslyn J L Wong; Pooja S Dimri; Lin L Su; Arijit Biswas; Sebastian E Illanes; Citra N Z Mattar; Ruby Y-J Huang; Mahesh Choolani
Journal:  Prenat Diagn       Date:  2020-10-04       Impact factor: 3.242

6.  SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes.

Authors:  Asma Khalil; Erkan Kalafat; Can Benlioglu; Pat O'Brien; Edward Morris; Tim Draycott; Shakila Thangaratinam; Kirsty Le Doare; Paul Heath; Shamez Ladhani; Peter von Dadelszen; Laura A Magee
Journal:  EClinicalMedicine       Date:  2020-07-03

7.  A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials.

Authors:  Katelyn A Pastick; Melanie R Nicol; Elizabeth Smyth; Rebecca Zash; David R Boulware; Radha Rajasingham; Emily G McDonald
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

8.  Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis.

Authors:  Alexander M Kotlyar; Olga Grechukhina; Alice Chen; Shota Popkhadze; Alyssa Grimshaw; Oded Tal; Hugh S Taylor; Reshef Tal
Journal:  Am J Obstet Gynecol       Date:  2020-07-31       Impact factor: 8.661

9.  COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission.

Authors:  Elicia Pettirosso; Michelle Giles; Stephen Cole; Megan Rees
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-08-10       Impact factor: 1.884

Review 10.  Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease.

Authors:  Albert L Hsu; Minhui Guan; Eric Johannesen; Amanda J Stephens; Nabila Khaleel; Nikki Kagan; Breanna C Tuhlei; Xiu-Feng Wan
Journal:  J Med Virol       Date:  2020-11-10       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.